C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2006
12/12/2006	CA2141175C A process for the production of tetrazolyl compounds
12/12/2006	CA2121871C A prophylactic or therapeutic drug for renal diseases
12/07/2006	WO2006130297A2 Solid forms of 1-( 5-(ih-i , 2 , 4 -triazol- 5 -yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
12/07/2006	WO2006129842A1 Novel aminopyridine derivative having selective aurora-a inhibitory activity
12/07/2006	WO2006129587A1 Pharmaceutical composition comprising pyrazolone derivative
12/07/2006	WO2006129583A1 Pyrazolone derivative
12/07/2006	WO2006129120A2 Benzotriazepinone derivatives
12/07/2006	WO2006129100A1 Novel compounds
12/07/2006	WO2006129064A1 Quinazolines and their use as aurora kinase inhibitors
12/07/2006	WO2006128920A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006	WO2006128791A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006	WO2006128693A2 2 -oxo-i -pyrrolidine derivatives/ processes for preparing them and their therapeutic use on the central nervous system
12/07/2006	WO2006128692A2 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	WO2006128585A1 Method for producing 2-(2-amino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid derivatives
12/07/2006	WO2006100082A3 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/07/2006	WO2006099256A3 Modulators of atp-binding cassette transporters
12/07/2006	WO2006084882A3 Substituted 4-(indol-3-yl)quinazolines and their use
12/07/2006	WO2006055831A3 Kinase inhibitors
12/07/2006	WO2005112919A8 Self-immolative linkers and drug conjugates
12/07/2006	WO2005112919A2 Self-immolative linkers and drug conjugates
12/07/2006	US20060276650 Pyrazole compounds
12/07/2006	US20060276648 Has improved reactivity and gives a fluorine-containing elastomer or cured product having an excellent solvent resistance, chemical resistance, releasing property, and water repellency; prepared by reacting a diester compound with an amine compound
12/07/2006	US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276526 Crystalline Form of Telmisartan Sodium
12/07/2006	US20060276525 Processes of preparing highly pure telmisartan form A, suitable for pharmaceutical compositions
12/07/2006	US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors
12/07/2006	US20060276523 Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276514 Tyrosine kinase inhibitors
12/07/2006	US20060276513 Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H- benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester
12/07/2006	US20060276511 Inhibitors of HCV replication
12/07/2006	US20060276509 Tripeptidyl peptidase inhibitors
12/07/2006	US20060276508 Amide derivatives as somatostatin receptor 5 antagonists
12/07/2006	US20060276506 Compounds for the treatment of inflammatory disorders
12/07/2006	US20060276488 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
12/07/2006	US20060276487 New compounds useful for DPP-IV enzyme inhibition
12/07/2006	US20060276485 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/07/2006	US20060276480 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
12/07/2006	US20060276479 Heterocyclic substituted piperazines with CXCR3 antagonist activity
12/07/2006	US20060276476 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
12/07/2006	US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276465 1,2-di(cyclic) substituted benzene compounds
12/07/2006	US20060276461 Prostaglandin analogs
12/07/2006	US20060276450 Isoquinoline potassium channel inhibitors
12/07/2006	US20060276449 depression, anxiety, neurodegenerative disorders, eating disorders, hypertension, gastrointestinal/immunological diseases, drug dependence, epilepsy, cerebral infarction/ischemia/edema, head trauma, inflammation, alopecia; arginine-vasopressin V1b receptor antagonists; metabolic stability
12/07/2006	US20060276448 Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity
12/07/2006	US20060276447 e.g. N-(2-Trifluoromethylphenyl)-N'-[(1-(6-trifluoromethyl-2-pyridyl)azetidin-3-yl)]urea; capsaicin receptor antagonist; analgesic, antiinflammatory agent; chronic, neuropathic, postoperative, postrheumatoid arthritic, osteoarthritic, back, visceral, cancer pain, algesia, neuralgia
12/07/2006	DE102005025225A1 Verfahren zur Herstellung von 2-(2-Amino-pyrimidin-4-yl)-1H-indol-5-carbonsäure-derivaten A process for the preparation of 2- (2-amino-pyrimidin-4-yl) -1H-indole-5-carboxylic acid derivatives
12/07/2006	CA2611134A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006	CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	CA2610042A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/07/2006	CA2609355A1 Organic compounds
12/07/2006	CA2606110A1 Solid forms of 1-(5-(1h-1,2,4-triazol-5-yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
12/06/2006	EP1728505A1 Preparation with elevated content
12/06/2006	EP1728504A1 Emulsion stabilizer
12/06/2006	EP1727816A1 Silylated carboxamides
12/06/2006	EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727806A1 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis
12/06/2006	EP1727799A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727798A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	EP0915871B1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
12/06/2006	CN1875073A Cyanine dye labelling reagents
12/06/2006	CN1875026A Platinum complex and luminescent element
12/06/2006	CN1874768A N3 alkylated benzimidazole derivatives as MEK inhibitors
12/06/2006	CN1288149C Double heterocyclic compound containing pyrazole and pyrazole ketone, preparing method and its use
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288147C Stable polymorph of FLIBANSERIN, technical process for its preparation and the use thereof for preparing medicaments
12/06/2006	CN1288146C Process for production of substituted aniline compound
12/05/2006	US7145008 Pyrimidine derivatives for the treatment of abnormal cell growth
12/05/2006	US7145005 making the crystalline citrate salt thereof; drug useful as histamine H3 receptor modulator
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144899 Thrombin inhibitors
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	US7144886 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents
12/05/2006	US7144880 Compositions relating to novel compounds and targets thereof
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
12/05/2006	CA2203079C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
12/05/2006	CA2185524C Ocular tension depressant
11/2006
11/30/2006	WO2006127576A2 N - formyl hydroxylamine compounds as pdf inhibitors
11/30/2006	WO2006127550A1 Proline bis-amide orexin receptor antagonists
11/30/2006	WO2006127203A2 Methods of synthesizing 6-alkylaminoquinoline derivatives
11/30/2006	WO2006126695A1 Pyrazole compound and therapeutic agent for diabetes comprising the same
11/30/2006	WO2006125972A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
11/30/2006	WO2006125324A1 Treatment of protein folding disorders
11/30/2006	WO2006111662A3 4h-1,2,4-triazin-5-one derivatives, their preparation and their use as alpha 7 nicotinic acetylcholine receptors
11/30/2006	WO2006095337A3 A process for the preparation of melamine cyanurate
11/30/2006	US20060270852 Preparation of bisquinoline compounds
11/30/2006	US20060270728 Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/30/2006	US20060270713 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/30/2006	US20060270711 Tenatoprazole salts and process of preparation thereof
11/30/2006	US20060270706 Cyclic amine derivative having heteroaryl ring
11/30/2006	US20060270702 Certain substituted ureas, as modulators of kinase activity
11/30/2006	US20060270701 Dipeptidyl peptidase-IV inhibitors
11/30/2006	US20060270692 2-(4-{[7-(3-chloropropoxy)-6-methoxyquinazolin-4-yl]amino}-1H-pyrazol-1-yl)-N-(3-fluorophenyl)acetamide; colorectal cancer
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270686 Anti-cancer agents and uses thereof
11/30/2006	US20060270683 Polymorphs of aripiprazole

1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 626